Vbi Vaccines Stock Price on September 16, 2024
VBIVQ Stock | 0.0005 0.0001 16.67% |
Below is the normalized historical share price chart for VBI Vaccines extending back to April 26, 2010. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of VBI Vaccines stands at 0.0005, as last reported on the 29th of December, with the highest price reaching 0.0005 and the lowest price hitting 0.0005 during the day.
If you're considering investing in VBI Stock, it is important to understand the factors that can impact its price. VBI Vaccines owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.0412, which indicates the company had a -0.0412% return per unit of volatility over the last 3 months. VBI Vaccines exposes twenty-one different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate VBI Vaccines' Standard Deviation of 29.16, market risk adjusted performance of (0.09), and Risk Adjusted Performance of (0.02) to confirm the risk estimate we provide.
At this time, VBI Vaccines' Capital Stock is relatively stable compared to the past year. As of 12/29/2024, Stock Based Compensation is likely to grow to about 8.6 M, while Total Stockholder Equity is likely to drop slightly above 7.2 M. . VBI Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
VBI |
Sharpe Ratio = -0.0412
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | VBIVQ |
Estimated Market Risk
29.62 actual daily | 96 96% of assets are less volatile |
Expected Return
-1.22 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.04 actual daily | 0 Most of other assets perform better |
Based on monthly moving average VBI Vaccines is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of VBI Vaccines by adding VBI Vaccines to a well-diversified portfolio.
VBI Vaccines Valuation on September 16, 2024
It is possible to determine the worth of VBI Vaccines on a given historical date. On September 16, 2024 VBI was worth 0.02 at the beginning of the trading date compared to the closed value of 0.02. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of VBI Vaccines stock. Still, in general, we apply an absolute valuation method to find VBI Vaccines' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of VBI Vaccines where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against VBI Vaccines' related companies.
Open | High | Low | Close | Volume | |
0.02 | 0.02 | 0.02 | 0.02 | 73,700 | |
09/16/2024 | 0.02 | 0.02 | 0.02 | 0.02 | 13,800 |
0.02 | 0.02 | 0.02 | 0.02 | 366,300 |
Backtest VBI Vaccines | | | VBI Vaccines History | | | VBI Vaccines Valuation | Previous | Next |
VBI Vaccines Trading Date Momentum on September 16, 2024
On September 17 2024 VBI Vaccines was traded for 0.02 at the closing time. The highest daily price throughout the period was 0.02 and the lowest price was 0.02 . The daily volume was 366.3 K. The net trading volume on 09/17/2024 did not result in any price rise and fall. The trading price change to current closing price is 0.00% . |
VBI Vaccines Fundamentals Correlations and Trends
By evaluating VBI Vaccines' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among VBI Vaccines' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. VBI financial account trend analysis is a perfect complement when working with valuation or volatility modules.About VBI Vaccines Stock history
VBI Vaccines investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for VBI is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in VBI Vaccines will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing VBI Vaccines stock prices may prove useful in developing a viable investing in VBI Vaccines
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 23.9 M | 13.6 M |
VBI Vaccines Stock Technical Analysis
VBI Vaccines technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
VBI Vaccines Period Price Range
Low | December 29, 2024
| High |
0.00 | 0.00 |
VBI Vaccines cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
VBI Vaccines December 29, 2024 Market Strength
Market strength indicators help investors to evaluate how VBI Vaccines stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading VBI Vaccines shares will generate the highest return on investment. By undertsting and applying VBI Vaccines stock market strength indicators, traders can identify VBI Vaccines entry and exit signals to maximize returns
VBI Vaccines Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for VBI Vaccines' price direction in advance. Along with the technical and fundamental analysis of VBI Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of VBI to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0.02) | |||
Jensen Alpha | (1.46) | |||
Total Risk Alpha | (2.00) | |||
Treynor Ratio | (0.10) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Additional Tools for VBI Stock Analysis
When running VBI Vaccines' price analysis, check to measure VBI Vaccines' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy VBI Vaccines is operating at the current time. Most of VBI Vaccines' value examination focuses on studying past and present price action to predict the probability of VBI Vaccines' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move VBI Vaccines' price. Additionally, you may evaluate how the addition of VBI Vaccines to your portfolios can decrease your overall portfolio volatility.